Biofarm S.A.'s latest marketcap:
As of 07/04/2025, Biofarm S.A.'s market capitalization has reached $187.76 M. According to our data, Biofarm S.A. is the 20572th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 187.76 M |
| Revenue (ttm) | 72.11 M |
| Net Income (ttm) | 20.01 M |
| Shares Out | 985.37 M |
| EPS (ttm) | 0.02 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 08/18/2025 |
| Earnings Date | 08/14/2025 |
Biofarm S.A.'s yearly market capitalization.
| Date | Market Cap(RON) | Change (%) | Global Rank |
|---|---|---|---|
| 07/04/2025 | 187.76 M | 11.76% | 20572 |
| 12/30/2024 | 703.55 M | -13.35% | 20885 |
| 12/29/2023 | 811.94 M | 33.77% | 19460 |
| 12/30/2022 | 606.99 M | -26.14% | 20562 |
| 12/30/2021 | 821.8 M | 94.86% | 19185 |
| 12/30/2020 | 421.74 M | 17.91% | 20283 |
| 12/30/2019 | 357.69 M | 11.69% | 19054 |
| 12/31/2018 | 320.24 M | 11.3% | 18514 |
| 12/29/2017 | 287.73 M | 8.15% | 19601 |
| 12/30/2016 | 266.05 M | -4.26% | 18305 |
Company Profile
About Biofarm S.A.
Biofarm S.A. is a leading Romanian pharmaceutical company specializing in the manufacture and sale of medicines. Established in 1921 and headquartered in Bucharest, the company serves both domestic and international markets.
Product Portfolio
Biofarm offers a diverse range of pharmaceutical products across multiple therapeutic areas, including:
- Antiallergics
- Cardiovascular and circulatory
- Analgesics and antipyretics
- Dermatology
- Digestive and metabolic
- Endocrine
- Genitourinary
- Multivitamins
- Ophthalmology
- Musculoskeletal
- Respiratory and ENT
- Neurology
Product Categories
The company provides:
- Prescription and non-prescription medicines
- Food supplements
- Medical devices
- Cosmetics
- Other healthcare products
Global Reach
In addition to serving the Romanian market, Biofarm exports its products to several countries, including:
- Azerbaijan
- Albania
- Georgia
- Iraq
- Kyrgyzstan
- Hungary
- Republic of Moldova
Frequently Asked Questions
-
What is Biofarm S.A.'s (BVB-BIO) current market cap?As of 07/04/2025, Biofarm S.A. (including the parent company, if applicable) has an estimated market capitalization of $187.76 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Biofarm S.A. (BVB-BIO) rank globally by market cap?Biofarm S.A. global market capitalization ranking is approximately 20572 as of 07/04/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.